GHRP-2

Growth Hormone SecretagogueResearch Use Only

Also known as: Growth Hormone Releasing Peptide 2, Pralmorelin, KP-102

GHRP-2 is a synthetic growth-hormone-releasing peptide and ghrelin-receptor agonist commonly referenced in research literature for potent stimulation of growth-hormone secretion. It is frequently studied alongside GHRH analogs to examine combined effects on the growth-hormone axis. This entry is educational and research-use-only and is not medical advice.

Typical range (research)

Commonly referenced in literature around 100–300 mcg per administration, one to three times daily (research reference only)

Half-life

~30 minutes (short-acting)

Route

Subcutaneous (research)

Common use

Studied as a growth-hormone secretagogue and appetite-related signaling peptide in research

Common vial sizes

5 mg · 10 mg

Storage

Lyophilized powder stored refrigerated or frozen away from light; reconstituted solution refrigerated (2–8 °C) and used within a few weeks

Stacking notes

Commonly paired with a GHRH analog such as CJC-1295 No DAC in research protocols

Reported side effects

Increased appetite reported anecdotallyTransient prolactin or cortisol elevation cited in studiesInjection-site reactionWater retention reported anecdotally

Regulatory note: Not an approved therapeutic; sold for research purposes only

Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.